![]() |
On August 14, 2026, the National Medical Products Administration (NMPA) issued Announcement No. 76 of 2026, approving 15 dental industry standards. Among them, the mandatory standard YY 0055-2026 "Dentistry - Dental Curing Lights" will take effect on August 1, 2029, specifying light source types and testing methods within the 380-515 nm wavelength range, replacing the previous YY 0055-2018 version. The announcement also clarified that relevant enterprises should promptly assess updates to technical requirements, testing methods, and registration documentation based on the standard's scope of application, replacement relationships, and implementation dates.
Recently, the Department of Stomatology at the Third Affiliated Hospital of Sun Yat-sen University published research in the leading orthodontics journal European Journal of Orthodontics, constructing for the first time a whole-transcriptome regulatory network of periodontal ligament tissue during orthodontic tooth movement. The study recruited 16 subjects aged 18-25, with the force-applied group sampled after 7 days of continuous force application. Sequencing revealed 337 upregulated mRNAs, 687 lncRNAs, and 377 circRNAs. circELP3 was found to regulate the TLR7/ITGAM axis involved in immune inflammation through competitive binding of hsa-miR-629-3p and hsa-miR-29b-2-5p. This research provides novel molecular clues for explaining how orthodontic forces regulate periodontal tissue remodeling through non-coding RNAs.
On August 15, 2026, TOPCHOICE MEDICAL CORPORATION released its 2026 first-half report, with revenue of RMB 1.586 billion, a year-on-year increase of 4.10%, and net profit attributable to shareholders of the parent company of RMB 458 million, up 32.70% year-on-year. Comprehensive dental business revenue reached RMB 427 million, an increase of 8.30%, with implant, orthodontics, and prosthodontics all achieving positive growth. In April, the company completed the acquisition of four optometry/vision care companies including Hangzhou Cunji Eyewear and Ningbo Guangji Vision Care, with a total transaction value of RMB 600 million. Cunji Eyewear achieved a net profit of RMB 35.2184 million. During the reporting period, the company operated 89 medical institutions, with over 3,100 dental treatment units and 4,757 professional medical staff.
On August 14, Dentium released its 2026 first-half report, with consolidated revenue of KRW 160.729 billion (approximately RMB 771 million), up 1.03% year-on-year; net profit attributable to shareholders of the parent company reached KRW 31.109 billion (approximately RMB 149 million), up 78.84%. Dental business profit declined 38.22%, while financial income rose to KRW 19.477 billion (approximately RMB 93.49 million), an increase of 400.54%. The Chinese market contributed revenue of KRW 71.862 billion (approximately RMB 345 million), accounting for 44.7%. The court has dismissed Align Partners' application for preliminary injunction, but its lawsuit seeking revocation of the shareholders' meeting resolution remains under first-instance review.
On August 14, 2026, MegaGen Implant released its 2026 first-half financial results, with operating revenue of RMB 821 million, a year-on-year increase of 21.3%, of which export share rose to 69%. Operating profit reached RMB 134 million, with net profit of RMB 119 million. R&D investment totaled RMB 32.88 million, accounting for 4.01% of revenue. As of June 30, the company's total assets stood at approximately RMB 2.396 billion, with implant fixtures and treatment chairs accounting for 76.1% of revenue in the product structure.
On August 20, 2026, Jibo Medical released its 2026 semi-annual report, achieving operating revenue of RMB 178 million in the first half, a year-on-year increase of 4.70%; net profit attributable to shareholders reached RMB 16.3156 million, up 18.44% year-on-year, with growth outpacing revenue. Net operating cash flow was RMB 39.6874 million, while net investing cash flow was RMB -9.5584 million. As of the end of the reporting period, total employees numbered 1,198, an increase of 53 from the beginning of the period; among them, 940 were medical staff, with their proportion rising from 76.86% at the start of the period to 78.46%.
On August 21, 2026, Dencare (Chongqing) Oral Care Co., Ltd. released its 2026 first-half report, with operating revenue of RMB 961 million, a year-on-year increase of 14.16%, and net profit attributable to shareholders excluding non-recurring items of RMB 91.8324 million, up 32.36% year-on-year. E-commerce and other channels contributed revenue of RMB 386 million, accounting for 40.18%; electric toothbrush revenue reached RMB 12.3721 million, an increase of 81.51%. The company entered the Vietnamese market for the first time. R&D investment totaled RMB 29.6023 million, up 14.69% year-on-year.
On August 18, 2026, Yingguan Dental Technology released its 2026 first-half report, with operating revenue of RMB 18.0038 million, a year-on-year decrease of 8.26%; net profit attributable to shareholders of RMB 4.0004 million, down 13.39% year-on-year, with gross margin declining to 43.01%. The report showed that government subsidies and VAT rebates totaled approximately RMB 3.02 million, accounting for 76.42% of net profit; Beijing region main business revenue share rose to 96.60%. The company has approved a profit distribution plan of RMB 15 cash dividend per 10 shares, totaling RMB 9.1668 million.
On August 6, 2026, a dental outpatient clinic in Cixi, Zhejiang Province, was ordered by the Cixi Municipal Market Supervision Administration to cease publishing and was fined a total of RMB 60,000 for publishing unreviewed medical advertisements on Xiaohongshu that also contained false claims. The fine included RMB 40,000 for publishing unreviewed advertisements and RMB 20,000 for false advertising content.
On October 1, 2026, Guangdong Province officially implemented the "Regulations on the Protection of Consumer Rights and Interests of Guangdong Province" and the "Guangdong Province Regulations on Promoting Consumer Rights Protection Collaboration in the Guangdong-Hong Kong-Macao Greater Bay Area," comprehensively prohibiting platforms from differential pricing based on big data, requiring livestream e-commerce to label AI-generated content, and strengthening protections for elderly and prepayment consumers. The regulations stipulate that e-commerce operators shall not set different prices for the same product under equivalent conditions, and prepayment services must notify consumers thirty days in advance and explore fund custody arrangements. The collaboration regulations promote cross-border consumer dispute resolution, with the Provincial Consumer Committee building and optimizing the "Guangdong-Hong Kong-Macao Greater Bay Area Consumer Complaint Transfer Platform" to enable one-click complaints and networked case transfers for consumers.
On August 20, 2026, Curve Dental announced a USD 200 million investment in developing its flagship product Curve Hero and native ecosystem, aiming to consolidate its approximately 20% market share in North America. CEO Dave Cormack projects that over 40% of dental practice management software vendors will exit the market within the next 36 to 48 months. Founded in 2004, the company specializes in cloud-based dental practice management software, offering integrated functions including scheduling, patient records, imaging, billing, patient communication, and payments, currently serving over 80,000 dental professionals across the United States and Canada.
On August 14, 2026, Premier Dental entered into an exclusive distribution agreement with Houston-based Forward Science, securing exclusive rights to distribute the FDA-cleared non-pharmacological oral wound dressing PerioStom in the US market. The product utilizes chitosan microsphere technology and can be directly placed into periodontal pockets following periodontal treatment, forming an adhesive protective barrier that aids gum healing and protects sensitive tissue. Forward Science CEO Robert J. Whitman noted that this partnership marks Premier's further expansion in the periodontal care segment.
On August 18, 2026, the UK dental regulator (GDC) published annual registration statistics showing the total number of Dental Care Professionals (DCPs) increased from 80,657 to 84,746, approximately 5% growth (net increase of 3,746), while dental technicians fell to 4,824, marking the sixth consecutive year of decline. Since 2025, the UK government has advocated cross-team collaboration in NHS dental reform, expanding clinical scope and training capacity for roles such as therapists, aiming to alleviate service pressure and promote a balanced talent structure amid technological transformation.
Recently, the American Dental Association (ADA) Health Policy Institute released dental specialty enrollment data for the 2021-2025 academic years. Orofacial pain program enrollment increased from 50 to 65 students, a 30% rise; dental public health decreased from 53 to 44 students, a 17% decline. During the same period, total DDS/DMD enrollment increased 10.3% to 28,925 students, with dental hygiene up 15%. In 2025, DDS/DMD graduates reached 7,015, breaking the 7,000 threshold for the first time. In April 2026, the ADA joined multiple organizations in calling on Congress to increase oral health funding; in its May 2026 article, it suggested that if current trends continue, dental graduate numbers could reach 8,000 by the end of the decade.
On August 14, 2026, Oregon Health & Science University received over USD 11 million in grants from the National Institutes of Health (NIH) to support four oral microbiome research projects and the "Portland Oral Health Research Training Program." Among them, Hui Wu received USD 2.1 million to study Streptococcus mutans-Candida albicans synergistic interactions, Justin Merritt received USD 2.9 million to research the RNA degradosome, Jens Kreth received nearly USD 3 million to study Streptococcus sanguinis microparticles, and the PORT program received USD 3.1 million for interdisciplinary training. Dean Ronald Sakaguchi noted that these grants will enhance oral health services and research capabilities.
On July 30, 2026, the team of Juan J. Segura-Egea at the School of Dentistry of the University of Seville, Spain, published a systematic review in the International Endodontic Journal, incorporating 57 studies covering 64,026 root-filled teeth. The study found that the detection rate of periapical lesions using panoramic radiography combined with periapical radiographs (52.4%) was similar to CBCT (50.4%), with tooth-level prevalence at 41.3% and patient-level at 20.5%. The research indicated that optimized 2D imaging combinations still hold considerable diagnostic reference value when CBCT is limited or cost considerations apply.
| About DGN:DentalGoodNews (DGN) is a trusted professional media platform dedicated to the global dental industry. We deliver in-depth coverage of corporate news, policy & regulation, investment & funding, and clinical frontiers — serving dental institutions, device manufacturers, investors, and industry researchers worldwide. Contact us: haodeya@dongxizixun.com |